BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30954460)

  • 1. Inherited non-alcoholic fatty liver disease and dyslipidemia due to monoallelic ABHD5 mutations.
    Youssefian L; Vahidnezhad H; Saeidian AH; Pajouhanfar S; Sotoudeh S; Mansouri P; Amirkashani D; Zeinali S; Levine MA; Peris K; Colombo R; Uitto J
    J Hepatol; 2019 Aug; 71(2):366-370. PubMed ID: 30954460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of non-alcoholic fatty liver disease caused by biallelic ABHD5 mutations.
    Adant I; Declercq M; Bird M; Bauters M; Boeckx N; Devriendt K; Cassiman D; Witters P
    J Hepatol; 2020 May; 72(5):1030-1032. PubMed ID: 32107051
    [No Abstract]   [Full Text] [Related]  

  • 3. Human germline hedgehog pathway mutations predispose to fatty liver.
    Guillen-Sacoto MJ; Martinez AF; Abe Y; Kruszka P; Weiss K; Everson JL; Bataller R; Kleiner DE; Ward JM; Sulik KK; Lipinski RJ; Solomon BD; Muenke M
    J Hepatol; 2017 Oct; 67(4):809-817. PubMed ID: 28645738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter.
    Missaglia S; Valadares ER; Moro L; Faguntes ED; Quintão Roque R; Giardina B; Tavian D
    BMC Med Genet; 2014 Mar; 15():32. PubMed ID: 24628803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
    Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
    J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease.
    Salvoza NC; Klinzing DC; Gopez-Cervantes J; Baclig MO
    PLoS One; 2016; 11(4):e0153497. PubMed ID: 27077736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin3 rs28365927 functional variant confers to the high risk of non-alcoholic fatty liver disease in Chinese Han population.
    Chen LJ; Guo J; Zhang SX; Xu Y; Zhao Q; Zhang W; Xiao J; Chen Y
    Lipids Health Dis; 2021 Aug; 20(1):92. PubMed ID: 34446002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CYP7A1 gene polymorphism and the characteristics of dyslipidemias in patients with nonalcoholic fatty liver disease concurrent with hypothyroidism].
    Zhaldak DA; Melekhovets OK; Orlovskyi VF
    Ter Arkh; 2017; 89(10):62-65. PubMed ID: 29171472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings.
    Eskiocak AH; Missaglia S; Moro L; Durdu M; Tavian D
    Lipids Health Dis; 2019 Dec; 18(1):232. PubMed ID: 31883530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD.
    Corradini E; Buzzetti E; Dongiovanni P; Scarlini S; Caleffi A; Pelusi S; Bernardis I; Ventura P; Rametta R; Tenedini E; Tagliafico E; Fracanzani AL; Fargion S; Pietrangelo A; Valenti LV
    J Hepatol; 2021 Sep; 75(3):506-513. PubMed ID: 33774058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease.
    Jamialahmadi O; Mancina RM; Ciociola E; Tavaglione F; Luukkonen PK; Baselli G; Malvestiti F; Thuillier D; Raverdy V; Männistö V; Pipitone RM; Pennisi G; Prati D; Spagnuolo R; Petta S; Pihlajamäki J; Pattou F; Yki-Järvinen H; Valenti L; Romeo S
    Gastroenterology; 2021 Apr; 160(5):1634-1646.e7. PubMed ID: 33347879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease.
    Ustyol A; Aycan Ustyol E; Gurdol F; Kokali F; Bekpınar S
    Scand J Clin Lab Invest; 2017 May; 77(3):205-209. PubMed ID: 28318371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-alcoholic fatty liver disease and dyslipidemia: An update.
    Katsiki N; Mikhailidis DP; Mantzoros CS
    Metabolism; 2016 Aug; 65(8):1109-23. PubMed ID: 27237577
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Ji F; Liu Y; Hao JG; Wang LP; Dai MJ; Shen GF; Yan XB
    Aging (Albany NY); 2019 Sep; 11(18):7847-7858. PubMed ID: 31548436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Could inherited predisposition drive non-obese fatty liver disease? Results from German tertiary referral centers.
    Krawczyk M; Bantel H; Rau M; Schattenberg JM; Grünhage F; Pathil A; Demir M; Kluwe J; Boettler T; Weber SN; Geier A; Lammert F;
    J Hum Genet; 2018 May; 63(5):621-626. PubMed ID: 29483677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of deleterious rare variants in MTTP, PNPLA3, and TM6SF2 in Japanese males and association studies with NAFLD.
    Boonvisut S; Yoshida K; Nakayama K; Watanabe K; Miyashita H; Iwamoto S
    Lipids Health Dis; 2017 Sep; 16(1):183. PubMed ID: 28950858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AGTR1 rs3772622 gene polymorphism increase the risk of nonalcoholic fatty liver disease patients suffer coronary artery disease in Northern Chinese Han population.
    Liu Y; Lu LL; Yuan DX; Geng N; Xuan SY; Xin YN
    Lipids Health Dis; 2016 Jun; 15():113. PubMed ID: 27342049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study.
    Julián MT; Pera G; Soldevila B; Caballería L; Julve J; Puig-Jové C; Morillas R; Torán P; Expósito C; Puig-Domingo M; Castelblanco E; Franch-Nadal J; Cusi K; Mauricio D; Alonso N
    Eur J Endocrinol; 2021 Apr; 184(4):587-596. PubMed ID: 33606661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent and joint correlation of PNPLA3 I148M and TM6SF2 E167K variants with the risk of coronary heart disease in patients with non-alcoholic fatty liver disease.
    Wu JT; Liu SS; Xie XJ; Liu Q; Xin YN; Xuan SY
    Lipids Health Dis; 2020 Feb; 19(1):29. PubMed ID: 32093693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause.
    Robeva R; Mladenović D; Vesković M; Hrnčić D; Bjekić-Macut J; Stanojlović O; Livadas S; Yildiz BO; Macut D
    Maturitas; 2021 Sep; 151():22-30. PubMed ID: 34446275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.